Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
about
Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis.TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications.Pathobiology of biliary epithelia.miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model.Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.The combination of an HDAC6 inhibitor and a somatostatin receptor agonist synergistically reduces hepato-renal cystogenesis in an animal model of polycystic liver disease.Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease
P2860
Q33873050-2E105418-A0E8-4909-88D6-1CE933EDD687Q38764445-347AF610-45DE-47F0-92F4-EAB66E0312EEQ38774569-05CBC000-B42F-48E4-BD1F-A58CF5E0745EQ39440062-A4EC0C22-3729-436F-8F13-48FD6649BA3AQ47446885-35C85D06-8D39-4D2E-AE15-661AF7D4C9C7Q48553032-3C943BBE-28EB-4B23-A1D7-7F0D40FAC9D6Q48821774-4FDF5682-A7A9-42EE-94D5-9EEAF2B15909Q49795322-5DC0F9A3-7104-4807-BC41-2B34AB0807B6Q51172729-57D87122-73C9-4C12-80E3-AB28522237F3Q57121976-90D253B2-BB79-4395-BA48-7F1C17E265CA
P2860
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@ast
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@en
type
label
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@ast
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@en
prefLabel
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@ast
Ursodeoxycholic acid inhibits ...... s of polycystic liver disease.
@en
P2093
P2860
P50
P1476
Ursodeoxycholic acid inhibits ...... ls of polycystic liver disease
@en
P2093
Ainhoa Portu
Aura D Urribarri
Elena Sáez
Elizabeth Hijona
Joost P H Drenth
Marco Marzioni
María J Perugorria
Miriam Úriz
Nicholas F LaRusso
Patricia Munoz-Garrido
P2860
P304
P356
10.1016/J.JHEP.2015.05.023
P50
P577
2015-06-01T00:00:00Z